Indicaciones. Vía de administración y Dosis. COMPRIMIDO. Cada comprimido contiene: Metamizol sódico. mg. Envase con 10 comprimidos. Fiebre. El metamizol es aproximadamente 10 veces más potente que el propiltiouracilo y FARMACOCINÉTICA El metimazol se absorbe rápidamente por vía gastro–. METAMIZOL SÓDICO BH y EGO Litiasis Renal Farmacocinética 30 Minutos Farmacodinamia ULTRASONIDO RENAL ESTUDIOS DE.
|Published (Last):||16 December 2004|
|PDF File Size:||12.38 Mb|
|ePub File Size:||10.80 Mb|
|Price:||Free* [*Free Regsitration Required]|
Combined administration of certain doses of opioid compounds with a non-steroidal anti-inflammatory drug can produce additive or supra-additive effects while reducing unwanted effects. We have recently reported that co-administration of metamizol with tramadol produces antinociceptive effect potentiation, after acute treatment. However, none information about the effect produced by the combination after chronic or repeated dose administration exists.
The aims of this study were to investigate whether the antinociceptive synergism produced by the combination of metamizol and tramadol The mechanism involved in the synergism of the antinociceptive effect observed with the combination of metamizol and tramadol in single dose cannot be attributed to a pharmacokinetic interaction, and other pharmacodynamic interactions have to be considered. On the other hand, when metamizol and tramadol were co-administered under repeated administrations, a pharmacokinetic interaction and tolerance development occurred.
This work shows an additional preclinical support for the combination therapy. The clinical utility of this combination in a suitable dose farmacocinetics should be evaluated in future studies. Opioid drugs remain the common choice for the treatment of pain of moderate to severe intensity. However, the usefulness of these drugs in treating chronic pain is limited due to the development of tolerance to the analgesic effect that occurs after repeated administrations, resulting in escalation of the dose administered and therefore to an increased incidence of adverse effects Gammaitoni et mteamizol.
A common strategy to maintain adequate analgesic effects and to reduce the adverse effects is to combine doses of opioid compounds with nonsteroidal anti-inflammatory drugs NSAIDs. Although some clinical and preclinical studies showing that combinations between opioids and NSAIDs can produce analgesic potentiation, little is known about the antinociceptive effects of repeated administrations. Some studies have shown good efficacy of the combination of tramadol and metamizol under preclinical conditions Planas et al.
Metamizol and tramadol are analgesic drugs with complex frmacocinetica of action, extensively used in combination in the management of acute postoperative pain in humans Poveda et al.
Other mechanisms such as the l -arginine-NO-cyclic GMP pathway and interaction with Farmacocineica d -aspartic acid receptors could be proposed to explain the antinociceptive synergism observed with the combination of such drugs. Tramadol is a central analgesic drug with a low affinity for opioid receptors. Tramadol is metabolized in the liver by two principal pathways: Only one of tramadol metabolites, M1, is pharmacologically active. Metamizol is a nonsteroidal anti-inflammatory drug that acts as an effective analgesic and antipyretic agent.
Metamizol is a pyrazolone derivative that inhibits the synthesis of prostaglandins at central and peripheral levels Alves and Duarte,Ortiz et al. AA is acetylated to 4-acetylaminoantipyrine AAA. It may be possible that metamizol and farmacofinetica could compete for the same enzymes, causing changes in the concentrations of metabolites of metamizol and consequently in the pharmacological effects produced.
The aims of this study were to investigate the farmacocknetica synergism produced by the combination of metamizol and tramadol Experiments were performed during farmqcocinetica light phase and animals were used only once. The number of experimental animals was kept to a minimum. At the conclusion of the study, rats were euthanized with CO 2 to avoid unnecessary suffering. Uric acid was fsrmacocinetica from Sigma Chemical Co St. Either metamizol or tramadol alone, or in combination was administered subcutaneously s.
The doses mentioned in the text refer to salts of these substances. Animals were randomly distributed into three farmacocineticca of 12 animals each. On the day of the experiment, rats under this treatment mftamizol a single dose of The MET-4D group received three daily doses of metamizol Blood samples were drawn in the group after administration of the drug, immediately after the antinociceptive effect was measured.
Group II was treated with the combination of metamizol and tramadol following the same administration schedules used for Group I. Animals in this group were randomly distributed into two subgroups of six rats each and the pharmacodynamics and pharmacokinetics of metamizol were studied after the simultaneous administration of metamizol Pharmacokinetics of MAA and AA metabolites and the antinociceptive effects of metamizol plus tramadol groups using the PIFIR model were determined in the same animal and blood samples were drawn following the same sampling scheme as in Group I.
On the day of the experiment, rats in Meramizol group received a single dose of TRA-4D group received three daily doses of tramadol No pharmacokinetic studies were conducted for this group.
Detailed methodology has been previously described. Immediately afterward, an farmacocijetica was attached to each hind-paw of the animals. The time of electrode contact on the cylinder was recorded with a computer controlled data acquisition system. After uric acid injection, rats developed progressive metaamizol of the injured limb. The time of contact of the injured hind limb reached a zero value 2. At this time, metamizol, tramadol or metamizol plus tramadol, previously dissolved in 0.
The time of electrode contact was recorded immediately before blood sampling at 0. Antinociception was evaluated as the recovery of the contact time of the injured limb. For the purpose of this study, inducing nociception in the experimental animals was unavoidable.
However, care was taken to avoid unnecessary suffering. The cannula was kept patent with heparinized saline solution and stopped with a needle. Rats were allowed to recover from anesthesia and the drugs were administered subcutaneously.
Blood samples were transferred to heparinized polypropylene tubes. The total volume of blood taken from each animal did not exceed 1. Extraction of main active metabolites of metamizol from plasma samples was conducted using a Solid Phase Extraction technique Meatmizol.
metamizol farmacocinetica pdf merge
The chromatographic system consisted of a Knauer high performance liquid darmacocinetica Berlin, Germany equipped with a Smartline pumpa Smartline PDA detector and a Smartline auto sampler The chromatographic station ClarityChrom V2. The mobile phase consisted of a mixture of water—methanol—triethylamine—acetic acid MAA and AA metabolite concentration-time curves were constructed and evaluated by non-compartmental analysis.
From the time courses obtained, the following pharmacokinetic parameters were determined: All parameters were obtained from the individual curves for each metabolite and for each treatment and the geometric mean was calculated. Non-compartmental analysis was performed farmacocnetica WinNonlin v.
Metxmizol analysis was performed using SPSS software v. Finally, cumulative farmxcocinetica under the effect—time curve AUC e vs.
The fit model for the relation between plasma concentration and antinociceptive effect was carried out using GraphPad Prism program v. The intra-articular injection of uric acid resulted in the complete dysfunction of the right paw in a period of approximately 2.
At this time zerodrugs were administered. At the doses of metamizol and tramadol used, no adverse effects that could interfere with the course of the study or the recording of the data were observed.
Overall antinociceptive effects after a single farmaccocinetica of Table 1 shows the pharmacodynamic parameters obtained after subcutaneous administration of tramadol The MET group showed an estimated maximal effect of However, when tramadol was administered alone acute administrationthe global effect was The global effect diminished significantly to Pharmacodynamic parameters obtained after subcutaneous administration of tramadol No parent drug metamizol concentrations were detected.
Time courses for MAA plasma concentrations are shown in Fig. Values decreased from The values ranged from 1. MAA plasma concentration—time curves. AA plasma concentration—time curves. Pharmacokinetic parameters for the two main active metabolites of metamizol after subcutaneous administration of Time courses for AA plasma concentrations are shown in Fig.
AUC 0—8h also showed a significant reduction from Results from different treatment schedules after administration of metamizol alone or in combination with tramadol are shown in Figure 3Figure 4 respectively. On the other hand, the relationship between the effect and AA metabolite plasma concentrations showed a mixed behavior, whereas the MET schedule exhibits a clockwise hysteresis and the MET-4D treatment showed a counter clockwise hysteresis Fig.
Finally, the cumulative areas under the effect—time curve were plotted against the cumulative areas under the farmacocineticz of metabolite plasma concentrations Figure 5Figure 6.
metamizol sodico farmacocinetica pdf
Data obtained after administration of metamizol alone in a single and chronic treatment fitted to the E max model. Data obtained after administration of metamizol plus tramadol in a single and chronic treatment fitted to the E max model. The overall effect was sustained during chronic treatments. The combination of metamizol and tramadol The development of tolerance to the antinociceptive effect was significantly increased with the drug co-administration of both drugs.
An increase in the rate of development of tolerance to the antinociceptive effect of metamizol co-administered with tramadol was previously reported using the plantar-test model Moreno-Rocha et al.
However, other pharmacokinetic interactions could be present, which are discussed afterward. In this study, possible changes in the pharmacokinetics of MAA or AA metabolites in rats, which could explain the pharmacological effects observed antinociceptive and tolerance development after administration of metamizol alone and in combination with tramadol, under acute and chronic treatments, were investigated.
To achieve this, the pharmacokinetics of MAA and AA metabolites, under the four treatments described, were followed. This is consistent with earlier studies in which the metabolite pharmacokinetics have been described Vlahov et al.
Under these conditions, the pharmacokinetic of metamizol in rats, is similar in some aspects with some results farmacocinetia in studies conducted in humans; meyamizol.
MIGRANOL by Pablo Pinilla on Prezi
It farmacocihetica be said that the pharmacokinetics of metamizol in acute treatment vary among species in parameter farmacocnetica obtained, but not in the relative proportion of the metabolites formed. Pharmacokinetic parameters obtained in this study in rats could not be compared with other studies, as scarce information was found.
So, it can be said that the synergism of the antinociceptive effect observed with the combination of metamizol and tramadol acute treatment cannot be attributed to a pharmacokinetic interaction.